Robeco Institutional Asset Management B.V.
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 1418773
ROTTERDAM, P7
Position in HRMY
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$3,573,896
+$652,145 QoQ
Shares Held
98,157
-5.9% QoQ
Ownership
0.169%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 328 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 52%
Shared 0%
None 48%
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Robeco Institutional Asset Management B.V. holds $992,672,242 across 15 Biotechnology names. HRMY ranks #10 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
460,602 | $287,203,771 | |
| 2 | INCY |
Incyte Corp
|
2,441,735 | $276,795,079 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
404,396 | $200,875,625 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
188,084 | $56,618,926 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,029,819 | $56,032,451 | |
| 6 | RPRX |
Royalty Pharma plc
|
911,586 | $51,112,627 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
117,612 | $28,340,963 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
408,215 | $23,358,062 |
All Filings in HRMY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,573,896 | 98,157 | Shares | Defined | 2026-07-21 | |
| 2026-03-31 | $2,921,751 | 104,311 | Shares | Defined | 2026-04-21 | |
| 2025-12-31 | $1,761,920 | 47,085 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $1,289,449 | 46,787 | Shares | Defined | 2025-10-22 | |
| 2025-06-30 | $1,478,469 | 46,787 | Shares | Defined | 2025-07-18 | |
| No filing history on record for this holder in this stock. | ||||||